Sectoral Asset Management
Latest statistics and disclosures from SECTORAL ASSET MANAGEMENT's latest quarterly 13F-HR filing:
- Top 5 stock holdings are NBIX, MRK, PFE, LLY, CELG. These five stock positions account for 22.06% of SECTORAL ASSET MANAGEMENT's total stock portfolio.
- Added to shares of these 10 stocks: PFE (+$41.98M), ABMD (+$26.75M), Global Blood Therapeutics In (+$16.38M), Adeptus Health Inc-class A (+$9.01M), Teladoc (+$7.83M), TEVA (+$5.37M), NXTM, NVAX, MOH, Acadia Healthcare.
- Started 8 new stock positions in ALNY, Seres Therapeutics, Agios Pharmaceuticals, Global Blood Therapeutics In, Aerie Pharmaceuticals, PFE, Intellia Therapeutics Inc Com stock, Neuroderm Ltd F.
- Reduced shares in these 10 stocks: CELG (-$106.72M), AMGN (-$102.37M), GILD (-$95.99M), (-$83.90M), BMRN (-$77.36M), INCY (-$72.39M), (-$61.06M), VRTX (-$57.20M), TMO (-$52.44M), ALXN (-$47.37M).
- Sold out of its positions in Aimmune Therapeutics, AKRX, AMGN, Amphastar Pharmaceuticals, Anacor Pharmaceuticals In, Ascendis Pharma A S, Pronai Therapeutics, BIIB, Cara Therapeutics, EW.
- As of June 30, 2016, SECTORAL ASSET MANAGEMENT has $968.42M in assets under management (AUM). Assets under management dropped from a total value of $2.07B to $968.42M.
- Independent of market fluctuations, SECTORAL ASSET MANAGEMENT was a net seller by $1.13B worth of stocks in the most recent quarter.
SECTORAL ASSET MANAGEMENT portfolio companies for June 2016 quarter
| Company (Ticker) | Portfolio Weight | Share Count | Price | Last Trade |
|---|---|---|---|---|
| Neurocrine Biosciences (NBIX) | 4.75 | 1.01M -38.00% | 45.45 | 40.28 |
| Merck & Co (MRK) | 4.42 | 742960 | 57.61 | 56.20 |
| Pfizer (PFE) | 4.34 | 1.19M NEW | 35.21 | 33.78 |
| Eli Lilly & Co. (LLY) | 4.31 | 529908 +4.00% | 78.75 | 68.81 |
| Celgene Corporation (CELG) | 4.24 | 416704 -72.00% | 98.63 | 118.26 |
| Gilead Sciences (GILD) | 4.10 | 476102 -70.00% | 83.42 | 99.53 |
| NxStage Medical (NXTM) | 4.09 | 1.83M +11.00% | 21.68 | 16.68 |
| BioMarin Pharmaceutical (BMRN) | 3.98 | 494836 -66.00% | 77.80 | 113.42 |
| Medtronic | 3.81 | 425333 -10.00% | 86.77 | 0.00 |
| ABIOMED (ABMD) | 3.37 | 298338 +456.00% | 109.29 | 58.77 |
| Adeptus Health Inc-class A | 3.30 | 619108 +39.00% | 51.66 | 0.00 |
| Dex (DXCM) | 3.23 | 394466 -30.00% | 79.33 | 58.66 |
| Teva Pharmaceutical Industries (TEVA) | 3.19 | 615935 +20.00% | 50.23 | 57.77 |
| Alexion Pharmaceuticals (ALXN) | 3.03 | 251348 -61.00% | 116.76 | 179.76 |
| Portola Pharmaceuticals | 3.00 | 1.23M -22.00% | 23.60 | 0.00 |
| Shire (SHPGY) | 2.82 | 148424 -63.00% | 184.08 | 0.00 |
| Acadia Healthcare | 2.75 | 480605 +14.00% | 55.40 | 0.00 |
| Amicus Therapeutics (FOLD) | 2.70 | 4.79M -48.00% | 5.46 | 8.99 |
| Teladoc | 2.42 | 1.46M +50.00% | 16.02 | 0.00 |
| UnitedHealth (UNH) | 2.12 | 145095 -17.00% | 141.20 | 113.33 |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.06 | 231575 -74.00% | 86.02 | 123.26 |
| Incyte Corporation (INCY) | 2.05 | 248459 -78.00% | 79.98 | 88.43 |
| Align Technology (ALGN) | 2.05 | 246127 -41.00% | 80.55 | 57.05 |
| Acceleron Pharma | 1.83 | 522294 -63.00% | 33.98 | 0.00 |
| Mylan Nv | 1.82 | 408170 -30.00% | 43.24 | 0.00 |
| Global Blood Therapeutics In | 1.69 | 987224 NEW | 16.59 | 0.00 |
| Sagent Pharmaceuticals | 1.56 | 1.01M -32.00% | 14.98 | 0.00 |
| Alder Biopharmaceuticals | 1.35 | 525221 -59.00% | 24.97 | 0.00 |
| Intuitive Surgical (ISRG) | 1.32 | 19274 -17.00% | 661.41 | 489.66 |
| Novo Nordisk A/S (NVO) | 1.20 | 216175 | 53.78 | 46.07 |
| NuVasive (NUVA) | 1.03 | 166300 | 59.72 | 44.67 |
| Intercept Pharmaceuticals In | 0.81 | 54651 -77.00% | 142.69 | 0.00 |
| Molina Healthcare (MOH) | 0.79 | 152900 +88.00% | 49.90 | 61.05 |
| AmSurg (AMSG) | 0.77 | 96400 | 77.54 | 60.82 |
| Ophthotech | 0.77 | 146800 -58.00% | 51.03 | 0.00 |
| Team Health Holdings | 0.74 | 175900 -34.00% | 40.67 | 0.00 |
| Novavax (NVAX) | 0.68 | 912305 +121.00% | 7.27 | 9.03 |
| Wright Medical Group Nv | 0.66 | 366975 +101.00% | 17.37 | 0.00 |
| Momenta Pharmaceuticals (MNTA) | 0.64 | 574040 -15.00% | 10.80 | 14.37 |
| Prothena | 0.63 | 174746 -56.00% | 34.96 | 0.00 |
| Integra LifeSciences Holdings (IART) | 0.50 | 60560 | 79.77 | 58.76 |
| Surgical Care Affiliates | 0.48 | 98300 +23.00% | 47.67 | 0.00 |
| Ptc Therapeutics I | 0.47 | 648976 -75.00% | 7.02 | 0.00 |
| Accuray Incorporated (ARAY) | 0.44 | 825875 +6.00% | 5.19 | 8.54 |
| Advaxis | 0.36 | 433859 -80.00% | 8.09 | 0.00 |
| Collegium Pharmaceutical Inc Common Stock Usd | 0.36 | 294400 | 11.85 | 0.00 |
| Regenxbio Inc equity us cm | 0.35 | 367541 -45.00% | 9.19 | 0.00 |
| Entellus Medical Cm | 0.28 | 146006 -2.00% | 18.27 | 0.00 |
| Uniqure Nv shs | 0.26 | 347271 -75.00% | 7.37 | 0.00 |
| Intersect Ent | 0.26 | 193140 +67.00% | 12.93 | 0.00 |
| Lannett Company (LCI) | 0.25 | 102693 -20.00% | 23.79 | 64.05 |
| Neuroderm Ltd F | 0.18 | 104971 NEW | 16.25 | 0.00 |
| Dr. Reddy's Laboratories (RDY) | 0.17 | 32155 -65.00% | 51.22 | 55.15 |
| Agios Pharmaceuticals | 0.16 | 36100 NEW | 41.88 | 0.00 |
| Aerie Pharmaceuticals | 0.16 | 88400 NEW | 17.60 | 0.00 |
| Sage Therapeutics | 0.16 | 52250 -87.00% | 30.12 | 0.00 |
| Intellia Therapeutics Inc Com stock | 0.15 | 123159 NEW | 11.90 | 0.00 |
| Pronai Therapeutics | 0.14 | 201660 -82.00% | 6.74 | 0.00 |
| ACADIA Pharmaceuticals (ACAD) | 0.10 | 29582 -95.00% | 32.45 | 43.70 |
| Avexis | 0.10 | 25672 -91.00% | 38.02 | 0.00 |
| China Biologic Products (CBPO) | 0.06 | 5890 | 106.28 | 81.57 |
| Alnylam Pharmaceuticals (ALNY) | 0.06 | 10000 NEW | 55.50 | 111.05 |
| Seres Therapeutics | 0.06 | 20600 NEW | 29.03 | 0.00 |
| Profound Medical | 0.06 | 541500 -47.00% | 1.12 | 0.00 |
Download CSV 
Past 13F-HR SEC Filings for SECTORAL ASSET MANAGEMENT
- SECTORAL ASSET MANAGEMENT 2016 Q1 filed May 13, 2016
- SECTORAL ASSET MANAGEMENT 2015 Q4 filed Feb. 12, 2016
- SECTORAL ASSET MANAGEMENT 2015 Q3 filed Nov. 13, 2015
- SECTORAL ASSET MANAGEMENT 2015 Q2 filed Aug. 13, 2015
- SECTORAL ASSET MANAGEMENT 2015 Q1 filed May 14, 2015
- SECTORAL ASSET MANAGEMENT 2014 Q4 filed Feb. 13, 2015
- SECTORAL ASSET MANAGEMENT 2014 Q3 filed Nov. 13, 2014
- SECTORAL ASSET MANAGEMENT 2014 Q2 filed Aug. 14, 2014
- SECTORAL ASSET MANAGEMENT 2014 Q1 filed May 14, 2014
- SECTORAL ASSET MANAGEMENT 2013 Q4 filed Feb. 12, 2014
- SECTORAL ASSET MANAGEMENT 2013 Q3 filed Nov. 13, 2013
- SECTORAL ASSET MANAGEMENT 2013 Q2 filed Aug. 12, 2013
- Sectoral Asset Management 2013 Q1 filed May 14, 2013
- Sectoral Asset Management 2012 Q4 filed Feb. 14, 2013
- Sectoral Asset Management 2012 Q3 filed Nov. 13, 2012
- Sectoral Asset Management 2012 Q2 filed Aug. 13, 2012
- Sectoral Asset Management 2012 Q1 filed May 14, 2012
- Sectoral Asset Management 2011 Q4 filed Feb. 22, 2012
- Sectoral Asset Management 2011 Q3 filed Nov. 14, 2011